Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2024
Guilherme Nader, PhD
Probing the role of nuclear mechanical confinement in the crosstalk between cancer...
Read More
2024
Christina Termini, PhD
Targeting the leukemia heparan sulfome to overcome chemotherapy resistance
Read More
2024
Megan Ruhland, PhD
Tissue complexity impacts anti-tumor dendritic cell function in melanoma
Read More
2024
Daniel Matson, MD, PhD
GATA2 Enables a Personalized Medicine Approach to Endometrial Serous Carcinoma
Read More
2024
Alex Kentsis, MD, PhD
Epigenetic liabilities for synthetic lethal targeting of refractory childhood sarcomas
Read More
2024
Michael Andreeff, MD, PhD
Co-targeting menin, RAS, and BCL-2 in KMT2A-rearranged pediatric acute leukemias
Read More
2024
M. Kohler, MD, PhD
Signaling Enhanced CAR T Cells for the Treatment of Pediatric Osteosarcoma
Read More
2024
Gabriel Griffin, MD
Harnessing Endogenous Retroviruses to Overcome Immunotherapy Resistance in Microsatellite-Stable Colorectal Cancer
Read More
2024
Brian Miller, MD, PhD
Dissecting metabolic vulnerabilities of tumor- associated macrophages to improve the efficacy of...
Read More
2024
Aram Modrek, MD, PhD
Decoding Glioblastoma Treatment Escape Mechanisms: Integrative Single-Cell and Single-Molecule Approaches
Read More
2024
Defne Bayik, PhD
Dipeptidyl peptidase 4 targeting to reinvigorate CD8+ T cells in glioblastoma
Read More
2024
Brandon Faubert, PhD
Elucidating the Role of Fatty Acid Metabolism During Lung Cancer Progression
Read More
2024
Tae Kon Kim, MD, PhD
Immune evasion mediated by LAIR1-collagen pathway in high risk myelodysplastic syndrome
Read More
2024
Kathleen Mulvaney, PhD
Identifying novel drug combinations to overcome therapeutic resistance in CDKN2A-null tumors
Read More
2024
Xin Cai, MD, PhD
Targeting Metabolite Signaling in Cancer Therapy
Read More
2024
Rachel Niec, MD, PhD, MS
Deciphering Inter- and Intra-Tissue Communication Networks in Colitis and Colitis-Associated Cancer: Hematopoietic...
Read More